Navigation Links


entecavir at Biology News

entecavir at Biology Products
entecavir at Biology Technology
entecavir at Medicine News

India Approves Baraclude? (entecavir) For Treatment Of Chronic HEPATITIS B

Bristol-Myers Squibb has announced the launch of BARACLUDE? (entecavir) for the treatment of chronic hepatitis B virus infection //following its approval by the Drug Controller General of India. BARACLUDE (entecavir) is indicated for the treatment of chronic hepatitis B virus infection in adults with evidence of active viral replication and either evidence of persistent elevations in...

Challenges in Entecavir Drug Treatment

According to a new report in the New England Journal of Medicine,treating hepatitis B patients with the drug entecavir can cause those who are also infected with HIV to become resistant to two of the most important drugs in the anti-HIV arsenal. the researchers reported that a patient infected with both hepatitis B and HIV who was treated with entecavir developed a mutant strain of H...
entecavir at Medicine Products
entecavir at Medicine Technology

Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load Reduction Compared to Adefovir at 48 Weeks in Study of Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients

WASHINGTON, May 21, 2007/PRNewswire-FirstCall/ -- Bristol-MyersSquibb Company (NYSE: BMY) today announced new data from studyETV-079, which showed that treatment with Baraclude (entecavir)demonstrated greater viral load reduction than adefovir at 48 weeks-- a result that was also seen at weeks 12 (primary endpoint) and24. These data from an open-label, randomized viral kinetics studyof 6...

Baraclude (entecavir) Therapy Resulted in Undetectable Levels of Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment

93 Percent of Nucleoside-Naive Chronic Hepatitis B e-Antigen(HBeAg)-Negative Patients Achieved Undetectable Viral Load by Week48 of Re-Treatment PRINCETON, N.J., April 13, 2007 /PRNewswire-FirstCall/ --Bristol-Myers Squibb Company today announced data from a cohort ofnucleoside-naive HBeAg-negative chronic hepatitis B patients(ETV-027/901, n=99). These data showed that patients whoexperi...
Other TagsMoHtape
(Date:11/18/2008)...and Sutent reverse, prevent autoimmune disease , ...eevec, a wonder drug that effectively treats leuke...betes, University of California San Francisco, re...hey found that Gleevec and a similar cancer drug, .... Type 1 diabetes is usually diagnosed in children...
(Date:11/18/2008)...- Wisconsin residents demonstrated their,desire t...od Neighbor Day, an,effort to collect recyclable ..., Truckloads of computers, electronics, clot... event Saturday. The items were brought by nearly ...Aurora hospitals and clinics. , Good Neighb...
(Date:11/18/2008)...sed risk of dangerous side effect , , T...d cancer drug Avastin appears to be associated wit...veins of patients with a variety of cancers. , ... side effects associated with the drug, including ...el perforation. , It has previously been recogn...
(Date:11/18/2008)...her problems have surfaced with these products, ex...y News) - American women who turn to cosmetic trea... be better informed as to the health risks these p...nd Drug Administration recommended Tuesday. , T...o revise product labeling to warn of potential rea...
Breaking Medicine News(10 mins):Health News:Cancer Drugs May Treat Type 1 Diabetes 2Health News:Eastern Wisconsin Residents Demonstrate Their Commitment to Being Good Neighbors 2Health News:Eastern Wisconsin Residents Demonstrate Their Commitment to Being Good Neighbors 3Health News:Cancer Drug Ups Risk of Clots in Veins 2Health News:Cancer Drug Ups Risk of Clots in Veins 3Health News:Wrinkle Fillers Need Better Label Warnings: FDA Panel 2Health News:Wrinkle Fillers Need Better Label Warnings: FDA Panel 3
(Date:11/17/2008)...DENA, Calif.--The bacterial cell wall that is the ... actually made up of a thin single layer of carboh...wrap around the bacterium like a belt around a per... at the California Institute of Technology (Caltec...ture in three dimensions was made possible by new ...
(Date:11/17/2008)...le are different, both physically and mentally, bu...n the thought of scientists for decades now. But w...mon, the University of Alberta,s Tim Caulfield is ...t attitudes. , Just last year Nobel Prize winni... responsible for creating differences in human int...
(Date:11/17/2008)...akech, Morocco, November 17, 2008 The Internation...as (ICCAT) will meet from November 17- 24 in Marra...e Mediterranean bluefin tuna from collapse. , I... impending collapse, with its own review panel say...ishery is an "international disgrace" and a "trave...
(Date:11/17/2008)...K RIDGE, Tenn., Nov. 17, 2008 -- A Cray XT high-pe...ergy,s (DOE) Oak Ridge National Laboratory is the ...ual ranking of the world,s top 500 computers ( www...t an annual international supercomputing conferenc...formance of 1.64 petaflops, (quadrillion floating ...
Breaking Biology News(10 mins):Caltech researchers get first 3-D glimpse of bacterial cell-wall architecture 2Could genetic research awaken racist attitudes? 2Tuna Commission to decide the future of Mediterranean bluefin 2Oak Ridge supercomputer is the world's fastest for science 2Oak Ridge supercomputer is the world's fastest for science 3Oak Ridge supercomputer is the world's fastest for science 4Pharmos Corporation to Present at the 2007 RBC Capital Markets Healthcare Conference 2114 1Pharmos Corporation to Present at the 2007 RBC Capital Markets Healthcare Conference 2114 2Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia 28AML 29 1014 1Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia 28AML 29 1014 2Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia 28AML 29 1014 3Methane from microbes 3A a fuel for the future 1516 1Brooks and the University of Florida Reach Research Agreement 7935 1Brooks and the University of Florida Reach Research Agreement 7935 2
Other Contentsinfertilityinfertilityinfertilityimmunologyimmunologyimmunologyimmunologyimmunologyimmunologyimmunologyimmunologyfilamentfilamentfilamentintermediateintermediateintermediateintermediateintermediateintermediateintermediateintermediateintermediateinsulininsulininsulininsulininsulininsulininsulininsulinspacespacespacespacespacespacespacespacespacespaceintermembrane